Virulence and Antimicrobial Resistance: Convergence or Divergence
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Microbiology in Human Health and Disease".
Deadline for manuscript submissions: closed (31 August 2023) | Viewed by 1639
Special Issue Editors
Interests: antimicrobial resistance; carbapenemases; MRSA; bacterial genomics
Interests: emerging infectious diseases; infectious disease epidemiology; infectious disease control and prevention; microbiology; molecular biology; epidemiology; PCR; infectious diseases; antibiotic resistance; antimicrobials
Special Issue Information
Dear Colleagues,
Antimicrobial resistance and virulence are among the most important properties of bacteria in practice, but traditionally they were considered by microbiologists as relatively independent phenomena. Even the results of research in these areas have been published in various journals. The situation changed dramatically after the appearance of genetic lines of Klebsiella possessing both the properties of multiple resistance and increased virulence. Today, this phenomenon is considered one of the global and serious threats to the health care system. The number of works on the problem is growing exponentially; a number of convergence mechanisms have already been described, but progress in the development of treatment methods is very small. Obviously, to solve this problem, a deeper understanding of evolution and the molecular mechanisms of convergence is required, which in turn requires fundamental research involving systems biology methods. Although the phenomenon of convergence has been found in Klebsiella, it is likely that its formation and distribution is not limited to this species. This Special Issue of the multidisciplinary journal Biomedicines provides a unique platform for researchers from various fields to join forces to curb convergence and virulence.
Dr. Sergey Sidorenko
Dr. Vladimir Ageevets
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial resistance
- virulence
- convergence
- gram-negative bacteria
- Klebsiella
